|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2003-9-8
|
|
pubmed:abstractText |
Neurofibromatosis Type 2 (NF2) is an intractable disorder predisposing to multiple, recurrent tumors of the central nervous system (CNS). To clarify the survival rate and characteristics that predict poor survival, we retrospectively reviewed clinical data in cases of NF2.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0022-3085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
99
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
480-3
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12959433-Adult,
pubmed-meshheading:12959433-Age of Onset,
pubmed-meshheading:12959433-Child,
pubmed-meshheading:12959433-Child, Preschool,
pubmed-meshheading:12959433-Female,
pubmed-meshheading:12959433-Follow-Up Studies,
pubmed-meshheading:12959433-Humans,
pubmed-meshheading:12959433-Infant,
pubmed-meshheading:12959433-Male,
pubmed-meshheading:12959433-Middle Aged,
pubmed-meshheading:12959433-Neurofibromatosis 2,
pubmed-meshheading:12959433-Prognosis,
pubmed-meshheading:12959433-Retrospective Studies,
pubmed-meshheading:12959433-Survival Analysis
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2.
|
|
pubmed:affiliation |
Department of Neurosurgery, Nagoya University, Postgraduate School of Medicine, Nagoya, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
